“…Similarly to PHBs, flotillins exist as 2 isoforms, flotillin-1 and flotillin-2, which are ubiquitously expressed scaffold proteins involved in various aspects of cell signaling, cytoskeleton remodeling, endocytosis, release of extracellular vesicles and protein trafficking. 43 To fulfill these functions, they directly interact with several proteins, including the EGF receptor, the kinases Lyn, Fyn, Lck, cRAF, MEK1, ERK2, cRAF, MEK1/2, ERK1/2, KSR1 the small GTPases Gαq, Rab11, β-catenin, γ-catenin, E-cadherin, N-cadherin, the adaptor protein ArgBP2, the adapter protein SORBS1 /CAP/Ponsin, the E3 ubiquitin-protein ligase Cbl, α-actinin or F-actin. As far as we know, no small molecules targeting flotillins has been discovered yet, but such agents could display interesting effects to treat several types of diseases, including cancers, immunological, cardiac and neurodegenerative disorders.…”